Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_DC85C792AD0C
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.
Journal
Annals of oncology
Author(s)
Özdemir B.C., Latifyan S., Perreau M., Fenwick C., Alberio L., Waeber G., Spertini F., de Leval L., Michielin O., Obeid M.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Publication state
Published
Issued date
12/2020
Peer-reviewed
Oui
Volume
31
Number
12
Pages
1775-1778
Language
english
Notes
Publication types: Letter
Publication Status: ppublish
Keywords
Hemophagocytic lymphohistiocytosis, anti-IL-6 therapy, immune checkpoint inhibitors, life-threatening immune-related adverse events
OAI-PMH
oai:serval.unil.ch:BIB_DC85C792AD0C
DOI
10.1016/j.annonc.2020.08.2101
Pubmed
32858151
Web of science
000591343500022
Create date
31/08/2020 11:40
Last modification date
12/10/2021 6:39
Usage data